Join the Influenza Virus Vaccine, Inactivated group to help and get support from people like you.
Influenza Virus Vaccine, Inactivated News (Page 3)
Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Cambridge, Mass — September 14, 2017 – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in people five years of a...
FDA Approves Flublok Quadrivalent Influenza Vaccine
MERIDEN, Conn., Oct. 11, 2016 /PRNewswire/ – Protein Sciences Corporation announced today that the FDA has approved its quadrivalent formulation of Flublok influenza vaccine. Flublok Quadrivalent...
Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...
FDA Approves Fluad (influenza vaccine, adjuvanted) for Prevention of Seasonal Influenza
November 24, 2015 – The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza...
Sanofi Pasteur Announces FDA Approval Of Fluzone Intradermal Quadrivalent
SWIFTWATER, Pa., Dec. 12, 2014 /PRNewswire/ – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has...
New Fluzone Quadrivalent Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults
• The first and only 4-strain influenza vaccine option for patients as young as six months of age, • Helps protect children and adults against additional influenza B strain, • Newes...
FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology
January 16, 2013 – The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression...
FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.
LONDON, Dec. 17, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus V...
FDA Approves Agriflu Seasonal Influenza Vaccine
ROCKVILLE, Md., Nov. 27, 2009--The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B. Agriflu,...